Henry S.
- Country
- Germany
- Department
- Hämatologie, Onkologie und Palliativmedizin
Research Overview
- Phase III Trial on Disease-Free Survival in Resected Pancreatic Ductal Adenocarcinoma Using Oxaliplatin or Gemcitabine-Based Chemotherapy Allocation by Transcriptomic Signature
- Phase III Trial on Preoperative Chemotherapy with Irinotecan, Oxaliplatin, and Capecitabine in Resectable Advanced Colon Cancer
Data & Insights
Has run more than one trial at 18 of 103 partner sites.
Specializations
Gastrointestinal Oncology
Specializes in advanced treatment approaches for colorectal cancer and pancreatic ductal adenocarcinoma, with particular focus on surgical and perioperative therapeutic strategies.
- Colon Cancer Management
- Pancreatic Cancer Treatment
- Perioperative Care
Investigates optimized treatment sequences in gastrointestinal cancers, particularly in the context of surgical interventions.
Precision Medicine
Focuses on developing personalized treatment approaches using genetic markers and treatment-specific signatures to guide therapeutic decisions in cancer care.
- Biomarker-Driven Therapy
- Personalized Chemotherapy
- Treatment Response Prediction
Explores innovative methods for tailoring chemotherapy regimens based on individual patient characteristics.
Surgical Oncology
Specializes in resectable cancer treatment with emphasis on timing and integration of systemic therapy with surgical interventions.
- Preoperative Treatment Strategies
- Multimodal Therapy
- Post-surgical Care
Investigates optimal treatment sequencing to improve surgical outcomes in gastrointestinal cancers.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.